In the world of cancer research, there is something called a Kaplan-Meier curve, which tracks the survival of patients in the trial of an experimental drug.
But every now and again the patients in the treatment arm will live longer than the patients in the control arm, and the two lines on the Kaplan-Meier will diverge.